Neumora Therapeutics, Inc. (NMRA) support and resistance · $283.5M cap
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
This page maps Neumora Therapeutics, Inc. (NMRA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
NMRA income-statement cache is thin, so levels here lean on the stock page until the next filing lands.
NMRA currently screens at market cap $283.5M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NMRA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NMRA quote page for the session range and the stock page for the full model.
Not investment advice.